Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period.

@article{Rosenman2008ClinicalCO,
  title={Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period.},
  author={David J Rosenman and Furman S. McDonald and Jon O. Ebbert and Patricia J. Erwin and Matthew L Labella and Victor M. Montori},
  journal={Journal of hospital medicine},
  year={2008},
  volume={3 4},
  pages={319-25}
}
BACKGROUND Hospitalists involved in perioperative care either stop or continue until the day of surgery renin-angiotensin-aldosterone system antagonists (either angiotensin-converting enzyme inhibitors [ACEI] or angiotensin II receptor subtype 1 antagonists [ARA]) in patients who use these agents chronically. This practice variation reflects uncertainty regarding the risks and benefits of either approach. PURPOSE The purpose of this study was to assess the clinical consequences of… CONTINUE READING